FreeStyle Lite system
Device
Abbott Laboratories
Total Payments
$1.1M
Transactions
4,877
Doctors
2,200
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $741,669 | 1,563 | 686 |
| 2020 | $155,248 | 752 | 317 |
| 2019 | $48,073 | 1,089 | 630 |
| 2018 | $1,908 | 115 | 73 |
| 2017 | $146,563 | 1,358 | 835 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $465,220 | 761 | 42.5% |
| Unspecified | $446,862 | 108 | 40.9% |
| Food and Beverage | $66,200 | 3,905 | 6.1% |
| Consulting Fee | $60,293 | 24 | 5.5% |
| Space rental or facility fees (teaching hospital only) | $20,500 | 24 | 1.9% |
| Travel and Lodging | $18,936 | 49 | 1.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,450 | 4 | 0.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,500 | 1 | 0.4% |
| Current or prospective ownership or investment interest | $3,500 | 1 | 0.3% |
Payments by Type
General
$646,598
4,769 transactions
Research
$446,862
108 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 09DY-02-18G03-01 ARCHITECT CMV IgG DESIGN VALIDATION | Abbott Laboratories | $250,000 | 0 |
| Combining Flash Glucose Monitoring and Online Peer Support to Improve Outcomes in Hispanic Spanish Speaking People with Type 2 Diabetes | Abbott Laboratories | $134,400 | 0 |
| Role of dietary habits in efficacy of bariatric surgery | Abbott Laboratories | $24,000 | 0 |
| Surgical or Medical Therapy for Pediatric Type 2 Diabetes (ST2OMP) | Abbott Laboratories | $5,543 | 0 |
| Diabetes Discharge Transition Continuous Glucose Monitor Study (CGM Study) | Abbott Laboratories | $4,984 | 0 |
| Function and Emotion in Everyday Life with T1D (FEEL-T1D) | Abbott Laboratories | $3,909 | 0 |
| Inpatient CGM use for COVID-19 - a reduction in healthcare worker contact risk | Abbott Laboratories | $3,758 | 0 |
| Impact of Flash Glucose Monitoring on Behavior Modification, Quality of Life, and Treatment Satisfaction in Non-Insulin Treated Patients with Type 2 Diabetes | Abbott Laboratories | $3,330 | 0 |
| REDCHiP: Reducing Emotional Distress for Childhood Hypoglycemia in Parents | Abbott Laboratories | $2,526 | 0 |
| Inpatient CGM use for COVID-19 - a reduction in healthcare worker contact risk. | Abbott Laboratories | $2,317 | 0 |
| Individualized Structured Meal Plans to Improve Glycemic Control in Adolescents with Type 1 Diabetes (T1D) | Abbott Laboratories | $1,590 | 0 |
| Evaluation of a Complex Behavioral Intervention for Young Adults with Diabetes: The resilient, empowered, active living-telehealth (REAL-T) study | Abbott Laboratories | $1,062 | 0 |
| Integrating CGM use into Primary Care Practice: a Diabetes Quality Improvement Project | Abbott Laboratories | $1,061 | 0 |
| The use of Libre to educate, motivate and activate adults with newly diagnosed type 2 diabetes to improve metabolic control and reduce their reliance on medication: A pilot study | Abbott Laboratories | $1,018 | 0 |
| Impact of Flash Glucose Monitoring on Behavior Modification, Quality of Life, and Treatment Satisfaction in Non-Insulin Treated Patients With Type 2 Diabetes | Abbott Laboratories | $1,018 | 0 |
| Impact of Joint Utilization of the Freestyle Libre Flash glucose monitoring system and flairz health app on glycemic control in patients with type 2 diabetes mellitus managed with prandial and basal insulin | Abbott Laboratories | $1,018 | 0 |
| Improving assessment and management of hyperglycemia in patients with diabetes and cancer receiving chemotherapy with glucocorticoids | Abbott Laboratories | $746.20 | 0 |
| Hypoglycemia During Inpatient Re-feeding A CGM pilot in Eating Disorders | Abbott Laboratories | $655.20 | 0 |
| Effect of Empagliflozin glucose variability (GV) and myocardial perfusion in type II diabetes (T2DM) | Abbott Laboratories | $616.97 | 0 |
| 2 DAY study: pilot study of time-restricted feeding in adult subjects with pre-diabetes or diabetes | Abbott Laboratories | $541.20 | 0 |
Top Doctors Receiving Payments for FreeStyle Lite system
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New Orleans, LA | $855,717 | 147 |
| , M.D | Internal Medicine | Boston, MA | $12,317 | 3 |
| , M.D | Internal Medicine | Elizabethtown, NC | $9,725 | 11 |
| , MD | Endocrinology, Diabetes & Metabolism | Minneapolis, MN | $8,972 | 12 |
| , M.D | Pediatric Endocrinology | Lamar, MO | $8,605 | 18 |
| , MD | Endocrinology, Diabetes & Metabolism | Spokane, WA | $5,403 | 10 |
| Irl Hirsch | Endocrinology, Diabetes & Metabolism | Seattle, WA | $5,231 | 11 |
| , M.D | Endocrinology, Diabetes & Metabolism | Los Angeles, CA | $5,156 | 11 |
| , M.D | Specialist | Escondido, CA | $4,777 | 9 |
| , D.O | Obesity Medicine | Sisters, OR | $4,377 | 11 |
| , M.D | Endocrinology, Diabetes & Metabolism | Oceanside, CA | $4,313 | 6 |
| , M.D | Family Medicine | Long Beach, CA | $4,191 | 10 |
| , M.D | Family Medicine | Sylmar, CA | $4,105 | 9 |
| , M.D | Endocrinology, Diabetes & Metabolism | Rancho Cucamonga, CA | $4,093 | 10 |
| , MD | Internal Medicine | Nashville, TN | $4,016 | 10 |
| , MD | Internal Medicine | Saint Paul, MN | $2,152 | 4 |
| , M.D | Internal Medicine | Burbank, CA | $1,957 | 2 |
| , M.D, MRCP | Endocrinology, Diabetes & Metabolism | Springfield, IL | $1,600 | 3 |
| , M.D | Internal Medicine | Bayamon, PR | $1,513 | 2 |
| , MD | Endocrinology, Diabetes & Metabolism | Ponce, PR | $1,424 | 2 |
| , M.D | Internal Medicine | San Juan, PR | $1,362 | 2 |
| , M.D | Family Medicine | Lewistown, PA | $1,200 | 1 |
| , M.D | Endocrinology, Diabetes & Metabolism | Northborough, MA | $999.80 | 1 |
| , MD | Endocrinology, Diabetes & Metabolism | New Orleans, LA | $859.12 | 10 |
| , M.D | Endocrinology, Diabetes & Metabolism | Brockton, MA | $836.27 | 3 |
Ad
Manufacturing Companies
- Abbott Laboratories $1.1M
Product Information
- Type Device
- Total Payments $1.1M
- Total Doctors 2,200
- Transactions 4,877
About FreeStyle Lite system
FreeStyle Lite system is a device associated with $1.1M in payments to 2,200 healthcare providers, recorded across 4,877 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2017 to 2021. In 2021, $741,669 was paid across 1,563 transactions to 686 doctors.
The most common payment nature for FreeStyle Lite system is "Education" ($465,220, 42.5% of total).
FreeStyle Lite system is associated with 20 research studies, including "09DY-02-18G03-01 ARCHITECT CMV IgG DESIGN VALIDATION" ($250,000).